Publications by authors named "Angelantonio Maglio"

Claim this Profile
K
Key role of thymic stromal lymphopoietin as a molecular target for biologic treatment of severe asthma.
Corrado Pelaia, James Melhorn, Giovanni Paoletti, Remo Poto, Angelantonio Maglio

Front Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma.
Antonio Maiorano, Anna Ferrante Bannera, Chiara Lupia, Daniela Pastore, Emanuela Chiarella, Angelantonio Maglio

Adv Respir Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the Arg16Gly β-Adrenergic Receptor Polymorphism on Long-Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype-Stratified, Multicenter Study.
Santi Nolasco, Evelina Fagone, Raffaele Campisi, Andrea Portacci, Giulia Scioscia, Angelantonio Maglio

Allergy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mindfulness-Based Interventions for Chronic Pulmonary Diseases: A Systematic Review of Effects on Anxiety, Depression, Stress, Dyspnea, and Quality of Life.
Alessia Bramanti, Colomba Pessolano, Marina Garofano, Angelantonio Maglio, Michele Ciccarelli

Bioengineering (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted Approach.
Maria D'Amato, Daniela Pastore, Chiara Lupia, Claudio Candia, Andrea Bruni, Angelantonio Maglio

J Clin Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab.
Danilo Di Bona, Massimo Bilancia, Claudia Crimi, Michelina Daddato, Alida Benfante, Angelantonio Maglio

Clin Exp Allergy· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving sustained remission in severe asthma: goals, challenges, issues and opportunities.
Alessandro Vatrella, Angelantonio Maglio

Expert Rev Respir Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study.
Claudia Crimi, Santi Nolasco, Alberto Noto, Angelantonio Maglio, Vitaliano Nicola Quaranta

J Allergy Clin Immunol Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis.
Corrado Pelaia, Claudia Crimi, Alida Benfante, Maria Filomena Caiaffa, Raffaele Campisi, Angelantonio Maglio

Respirology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?
Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, Daniela Pastore, Angelantonio Maglio

Pragmat Obs Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report.
Antonio Maiorano, Chiara Lupia, Nicola Montenegro, Giuseppe Neri, Andrea Bruni, Angelantonio Maglio

Front Med (Lausanne)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study.
Corrado Pelaia, Anna Ferrante Bannera, Fioramante Lello Rotundo, Francesco Giuseppe Tropea, Giuseppe Armentaro, Angelantonio Maglio

Int J Chron Obstruct Pulmon Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience.
Giulia Scioscia, Pasquale Tondo, Santi Nolasco, Corrado Pelaia, Giovanna Elisiana Carpagnano, Angelantonio Maglio

J Clin Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis.
Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, Caterina Tinello, Luca Gallelli

J Clin Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps.
Corrado Pelaia, Alida Benfante, Maria Teresa Busceti, Maria Filomena Caiaffa, Raffaele Campisi, Angelantonio Maglio

Front Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study.
Angelantonio Maglio, Carolina Vitale, Corrado Pelaia, Maria D'Amato, Luigi Ciampo

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting.
Carolina Vitale, Angelantonio Maglio, Corrado Pelaia, Maria D'Amato, Luigi Ciampo

J Clin Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma.
Alessandro Vatrella, Angelantonio Maglio, Corrado Pelaia, Luigi Ciampo, Giulia Pelaia

Biomedicines· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Coronary Syndrome in Patients with SARS-CoV-2 Infection: Pathophysiology and Translational Perspectives.
Francesco P Cancro, Michele Bellino, Luca Esposito, Stefano Romei, Mario Centore, Angelantonio Maglio

Transl Med UniSa· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β.
Chiara Colarusso, Michela Terlizzi, Angelantonio Maglio, Antonio Molino, Claudio Candia

Front Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13.
Corrado Pelaia, Giulia Pelaia, Claudia Crimi, Angelantonio Maglio, Giuseppe Armentaro

Vaccines (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Biological Therapies for Severe Asthma Endotypes.
Corrado Pelaia, Giulia Pelaia, Claudia Crimi, Angelantonio Maglio, Anna Agnese Stanziola

Biomedicines· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets.
Corrado Pelaia, Enrico Heffler, Claudia Crimi, Angelantonio Maglio, Alessandro Vatrella

Front Pharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems.
Valeria Visco, Carolina Vitale, Antonella Rispoli, Carmine Izzo, Nicola Virtuoso, Angelantonio Maglio

J Clin Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β.
Chiara Colarusso, Angelantonio Maglio, Michela Terlizzi, Carolina Vitale, Antonio Molino

Biomedicines· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis